Auris Medical to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference on Tuesday, July 12
July 08 2016 - 8:03AM
Auris Medical Holding AG (NASDAQ:EARS), a clinical-stage company
dedicated to developing therapeutics that address important unmet
medical needs in otolaryngology, today announced that Bettina M.
Stubinski, MD, MBA, Chief Medical Officer, will present at Cantor
Fitzgerald's 2nd Annual Healthcare Conference in New York City on
Tuesday, July 12, 2016, at 1:30 pm EDT. A live webcast of the event
will be available through the Events and Presentations page in the
Investors section of the Auris Medical website at
www.aurismedical.com, and a replay of the presentation will be
available following the event.
About Auris Medical
Auris Medical is a Swiss biopharmaceutical company
dedicated to developing therapeutics that address important unmet
medical needs in otolaryngology. The Company is currently focusing
on the Phase 3 development of treatments for acute inner ear
tinnitus (KeyzilenTM; AM-101) and for acute inner ear hearing loss
(AM-111) by way of intratympanic administration with biocompatible
gel formulations. In addition, Auris Medical is pursuing
early-stage research and development projects. The Company was
founded in 2003 and is headquartered in Zug, Switzerland. The
shares of the parent company Auris Medical Holding AG trade on the
NASDAQ Global Market under the symbol "EARS."
Contact: Cindy McGee, Head of Investor Relations
and Corporate Communications, +41 61 201 1350,
investors@aurismedical.com
HUG#2027157
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Oct 2023 to Oct 2024